(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.33%.
Precision Biosciences's earnings in 2026 is -$52,732,000.On average, 7 Wall Street analysts forecast DTIL's earnings for 2026 to be -$78,998,408, with the lowest DTIL earnings forecast at -$95,755,311, and the highest DTIL earnings forecast at -$49,268,774. On average, 7 Wall Street analysts forecast DTIL's earnings for 2027 to be -$66,387,258, with the lowest DTIL earnings forecast at -$85,205,997, and the highest DTIL earnings forecast at -$42,023,366.
In 2028, DTIL is forecast to generate -$62,641,727 in earnings, with the lowest earnings forecast at -$77,091,140 and the highest earnings forecast at -$46,660,427.